GRDN (Guardian Pharmacy Services) Other Stockholders Equity: $0 Mil (As of Mar. 2026)


GRDN Guardian Pharmacy Services Inc GRDN
42 GF Score
Price $40.96
! 4 Warning Signs
View Full Analysis

What is Guardian Pharmacy Services Other Stockholders Equity?

Guardian Pharmacy Services GRDN -0.24% 42 Other Stockholders Equity is $0 Mil as of Mar. 2026. GuruFocus rates GRDN with a GF Score™ of 42/100. The stock has 4 warning signs investors should review.

Guardian Pharmacy Services's Other Stockholders Equity for the quarter that ended in Mar. 2026 was $0 Mil.

Guardian Pharmacy Services's quarterly Other Stockholders Equity declined from Sep. 2025 ($0 Mil) to Dec. 2025 ($-0 Mil) but then increased from Dec. 2025 ($-0 Mil) to Mar. 2026 ($0 Mil).

Guardian Pharmacy Services's annual Other Stockholders Equity declined from Dec. 2023 ($28 Mil) to Dec. 2024 ($0 Mil) and declined from Dec. 2024 ($0 Mil) to Dec. 2025 ($-0 Mil).

Guardian Pharmacy Services Other Stockholders Equity Historical Data

* Premium members only.

The historical data trend for Guardian Pharmacy Services's Other Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guardian Pharmacy Services Other Stockholders Equity Chart

Guardian Pharmacy Services Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Stockholders Equity
Get a 7-Day Free Trial 24.11 42.73 28.21 0.00 -0.00

Guardian Pharmacy Services Quarterly Data
Dec20 Mar21 Sep21 Dec21 Mar22 Jun22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.00 0.00
GRDN
42GF Score
Guardian Pharmacy Services Inc GRDN
Other Stockholders Equity is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guardian Pharmacy Services Other Stockholders Equity Calculation

Other Stockholders Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. GuruFocus lists following items in "Total Stockholders Equity" section:
Common Stock
Preferred Stock
Retained Earnings
Accumulated other comprehensive income (loss)
Additional Paid-In Capital
Treasury Stock
Other Stockholders Equity

What does a Other Stockholders Equity of $0 Mil mean?
Guardian Pharmacy Services (GRDN) has a Other Stockholders Equity of $0 Mil as of Mar. 2026. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Guardian Pharmacy Services and its competitors.
Is Guardian Pharmacy Services' Other Stockholders Equity too high?
Guardian Pharmacy Services' current Other Stockholders Equity is $0 Mil. Overall, Guardian Pharmacy Services has a GF Score™ of 42/100, reflecting its overall financial health beyond just this single metric.
How does Guardian Pharmacy Services' Other Stockholders Equity compare to ACHC and ASTH?
Guardian Pharmacy Services' Other Stockholders Equity of $0 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Stockholders Equity for a Healthcare Providers & Services company?
A good Other Stockholders Equity depends on the Healthcare Providers & Services industry context. However, Other Stockholders Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Stockholders Equity mean?
A high Other Stockholders Equity can signal that a stock is expensive relative to its fundamentals. Other Equity is instruments issued by the company that cannot be identified by other specific items in the Equity section. View historical data on Guardian Pharmacy Services and its competitors. Guardian Pharmacy Services's current Other Stockholders Equity is $0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guardian Pharmacy Services stock overvalued right now?
Guardian Pharmacy Services (GRDN) has a current Other Stockholders Equity of $0 Mil. The current Other Stockholders Equity is $0 Mil. Guardian Pharmacy Services' overall GF Score™ is 42/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Stockholders Equity calculated?
Other Stockholders Equity is calculated from a company's financial statements. For Guardian Pharmacy Services (GRDN), the current Other Stockholders Equity is $0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Guardian Pharmacy Services Business Description

Address 300 Galleria Parkway SE, Suite 800, Atlanta, GA, USA, 30339
Guardian Pharmacy Services Inc is a pharmacy services company providing technology-enabled services to help residents of long-term health care facilities (LTCFs) adhere to appropriate drug regimens, reducing the cost of care and improving clinical outcomes. The Company provides high-touch clinical, drug dispensing, and administration services tailored to residents in assisted living facilities, behavioral health facilities, and group homes, while also serving residents in all types of LTCFs. It partners with residents, LTCFs, and health plan payors to help reduce errors in drug administration, manage drug regimens, and improve adherence. The Company derives its revenue mainly from the sale of pharmaceutical and medical products.
42GF Score

Get the complete analysis for GRDN

Other Stockholders Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$40.96
Price